Login / Signup

Results of a randomized phase III/IV trial comparing intermittent bolus versus continuous infusion of antihaemophilic factor (recombinant) in adults with severe or moderately severe haemophilia A undergoing major orthopaedic surgery.

Ingrid Pabinger-FaschingVasily MamonovJerzy WindygaWerner EnglJennifer DoraltSrilatha TangadaGerald SpottsBruce Ewenstein
Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2021)
CI administration of antihaemophilic factor (recombinant) is a viable alternative to BI in patients with haemophilia A undergoing major orthopaedic surgery, providing comparable efficacy and safety.
Keyphrases